- Review Nanoparticle targeting for generation of anti-tumor immunity.
- Identify characteristics of tumor immune-microenvironment.
- Understand immunologic changes in patients receiving checkpoint blockade therapy.
07/28/2016 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Kavita Dhodapkar, MD